動物感染疾病診斷的全球市場:現狀分析、預測 (2022年~2028年)
市場調查報告書
商品編碼
1241363

動物感染疾病診斷的全球市場:現狀分析、預測 (2022年~2028年)

Global Veterinary Infectious Disease Diagnostics Market: Current Analysis and Forecast (2022-2028)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 147 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

由於動物傳染病很難診斷,因此進行了廣泛的研究,這推動了動物傳染病診斷市場的成長。此外,飼養動物數量增加和傳染病的流行也促進了市場的成長。由於私營公司和政府之間的合作,預計動物傳染病診斷市場將以8%左右的速度穩定成長。

本報告提供全球動物感染疾病診斷的市場調查,市場定義和概要,市場成長的各種影響因素分析,市場規模的變化、預測,各種區分、各地區/主要國家的明細,法律制度,供需趨勢,競爭環境,主要企業簡介等彙整資訊。

目錄

第1章 簡介

第2章 調查手法、前提條件

第3章 市場概要

第4章 摘要整理

第5章 COVID-19:對動物感染疾病診斷市場的影響

第6章 動物感染疾病診斷市場:收益的變化、預測

第7章 市場洞察:各技術

  • 免疫診斷
  • 分子診斷
  • 其他

第8章 市場洞察:各類型

  • 寵物
  • 食品生產動物

第9章 市場洞察:各感染類型

  • 細菌感染疾病
  • 病毒感染疾病
  • 寄生蟲感染疾病
  • 其他

第10章 市場洞察:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第11章 動物感染疾病診斷市場:市場動態

  • 推動市場要素
  • 市場課題
  • 影響分析

第12章 動物感染疾病診斷市場:市場機會

第13章 動物感染疾病診斷市場:市場趨勢

第14章 需求側、供給側的分析

第15章 價值鏈分析

第16章 競爭模式

第17章 企業簡介

  • BIOMERIEUX
  • Heska Corporation
  • IDEXX
  • Innovative Diagnostics
  • INDICAL BIOSCIENCE GmbH
  • Neogen Corporation
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific
  • Virbac
  • Zoetis

第18章 免責聲明

簡介目錄
Product Code: UMME211680

Infectious diseases are disorders caused by organisms such as bacteria, viruses, fungi, or parasites. The frequently occurring infectious diseases in animals are avian influenza virus and rabies virus. The diagnosis of infectious diseases is extremely difficult owing to the lack of symptoms in the animals. Therefore, huge research has been done in the sector, thus driving the growth of the market. Moreover, The rising adoption of animals and the increasing prevalence of infectious diseases among them are attributed to the market growth of the veterinary infectious disease diagnostics market. For instance, according to the Centers for Disease Control (CDC), Scientists estimate that more than 6 out of every 10 known infectious diseases in people can be spread from animals, and 3 out of every 4 new or emerging infectious diseases in people come from animals.

The Veterinary Infectious Disease Diagnostics Market is expected to grow at a steady rate of around 8% owing to the collaboration of private companies and governments. For instance, in January 2023, Alveo Technologies and the government of Barbados collaborate to co-develop advanced molecular disease diagnostics across multiple end markets.

Based on the technology, the market has been categorized into immunodiagnostics, molecular diagnostics, and others. Among them, the immunodiagnostics segment held a dominant share of the market in 2021. Immunodiagnostics is a technique of detection by using the ability of antibodies to bind to an antigen specifically. Factors such as the high efficiency of the technique, its cost-effective method of diagnostics, and it provides fast results are responsible for the dominating share of the segment.

Based on the animal type, the market has been categorized into companion animals and food-producing animals. Among them, the companion animals segment is anticipated to witness the fastest growth in the market. The increasing adoption of the companion animals such as dogs and cats is an important reason for the growth of the companion animal segment. For instance, according to the Zebra survey, 12.8% of Americans adopted a pet in 2020.

Based on the infection type, the market has been categorized into bacterial infections, viral infections, parasitic infections, and others. Among them, the parasitic infections segment holds a prominent share of the market. This is mainly owing to the increasing number of parasitic infections such as Ehrlichiosis and helminths in animals.

For a better understanding of the market adoption of the veterinary infectious disease diagnostics industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America is anticipated held a dominant market share in 2020. This is mainly due to the initiative taken by governmental organizations, higher adoption of pets, and favorable pet insurance policies. For instance, as per NAPHIA's 2022 State of the Industry Report, more than 4.41 million pets were insured in North America in 2021, up from 3.45 million in 2020.

Some of the major players operating in the market are BIOMERIEUX; Heska Corporation; IDEXX; Innovative Diagnostics; INDICAL BIOSCIENCE GmbH; Neogen Corporation; Randox Laboratories Ltd.; Thermo Fisher Scientific; Virbac.; and Zoetis.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Veterinary Infectious Disease Diagnostics Market
  • 2.2. Research Methodology of the Veterinary Infectious Disease Diagnostics Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET

6 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY TECHNOLOGY

  • 7.1. Immunodiagnostics
  • 7.2. Molecular Diagnostics
  • 7.3. Others

8 MARKET INSIGHTS BY ANIMAL TYPE

  • 8.1. Companion Animals
  • 8.2. Food-Producing Animals

9 MARKET INSIGHTS BY INFECTION TYPE

  • 9.1. Bacterial Infections
  • 9.2. Viral Infections
  • 9.3. Parasitic Infections
  • 9.4. Others

10 MARKET INSIGHTS BY REGION

  • 10.1. North America
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of Asia-Pacific
  • 10.4. Rest of World

11 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OPPORTUNITIES

13 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

  • 16.1. Competitive Landscape
    • 16.1.1. Porters Fiver Forces Analysis

17 COMPANY PROFILED

  • 17.1. BIOMERIEUX
  • 17.2. Heska Corporation
  • 17.3. IDEXX
  • 17.4. Innovative Diagnostics
  • 17.5. INDICAL BIOSCIENCE GmbH
  • 17.6. Neogen Corporation
  • 17.7. Randox Laboratories Ltd.
  • 17.8. Thermo Fisher Scientific
  • 17.9. Virbac
  • 17.10. Zoetis

18 DISCLAIMER